Counterterror supplement program
This article was originally published in The Tan Sheet
Executive Summary
Humanetics will develop dietary supplements to protect humans from effects of radiation poisoning under an R&D deal with the Uniformed Services University of the Health Sciences, the firm announced Feb. 8. Humanetics (Minneapolis) and USU's Armed Forces Radiobiology Research Institute "are currently targeting several compounds - some of which have already been shown to be effective in increasing survival in mice receiving lethal doses of radiation." Products under development will aim to protect the immune system during radiation exposure...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.